Epigenetic Cancer Therapy

ISBN 13: 9780128002063

Epigenetic Cancer Therapy

Valutazione media 0
( su 0 valutazioni fornite da Goodreads )
 
9780128002063: Epigenetic Cancer Therapy

Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector.

The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver).

The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.

  • Concisely summarizes the therapeutic implications of recent, large-scale epigenome studies, including the cancer epigenome atlas
  • Discusses targeted isoform specific versus pan-specific inhibitors, a rational drug design approach to epigenetics relevant to pharmacoepigenetic clinical applications
  • Covers new findings in the interplay between cancer stem cells (CSCs) and drug resistance, demonstrating that epigenetic machinery is a candidate target for the eradication of these CSCs

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

From the Back Cover:

Epigenetic Cancer Therapy articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. The book covers the basic background of the epigenome, aberrant epigenetics and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in lung, breast, prostate, liver, and other specific cancers. It also encompasses both large scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventive strategies.

Epigenetics represents a unique potential therapeutic vista that is emerging at a critical time, and as it has been suggested that a 1% reduction in cancer deaths would be worth $500 billion to the USA, almost 2.5 times what it spends annually on this disease. Uniting issues central to a translational audience, Epigenetic Cancer Therapy is indispensable reading for cancer specialists and oncologists, clinicians, researchers, academics, students, government bodies, and decision makers in the healthcare sector.

Review:

"...a helpful reference for researchers and medical professionals interested in epigenetics...contains many resources that may be useful for readers or guide them to technologies and areas of interest quickly. Score: 84 - 3 Stars" --Doody's

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Editore: Elsevier Science Publishing Co Inc, United States (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Quantità: 10
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Elsevier Science Publishing Co Inc, United States, 2015. Hardback. Condizione libro: New. Language: English . Brand New Book. Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector. The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver). The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Codice libro della libreria AA59780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 96,77
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: Italia
Destinazione, tempi e costi

2.

Editore: Academic Press (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Prima edizione Quantità: 1
Valutazione libreria
[?]

Descrizione libro Academic Press, 2015. Condizione libro: New. Editor(s): Gray, Steven. Num Pages: 748 pages, 50. BIC Classification: MFCC; MJCL. Category: (P) Professional & Vocational. Dimension: 200 x 242 x 42. Weight in Grams: 1722. . 2015. 1st Edition. Hardcover. . . . . . Codice libro della libreria V9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 100,92
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Irlanda a: Italia
Destinazione, tempi e costi

3.

Steven Gray (editor)
Editore: Elsevier Science 2015-08-24, Amsterdam (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Quantità: 1
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Elsevier Science 2015-08-24, Amsterdam, 2015. hardback. Condizione libro: New. Codice libro della libreria 9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 96,78
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,48
Da: Regno Unito a: Italia
Destinazione, tempi e costi

4.

Editore: Elsevier Science Publishing Co Inc, United States (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Quantità: 10
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Elsevier Science Publishing Co Inc, United States, 2015. Hardback. Condizione libro: New. Language: English . Brand New Book. Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector. The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver). The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Codice libro della libreria AA59780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 103,13
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: Italia
Destinazione, tempi e costi

5.

Editore: Academic Press
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Quantità: 1
Da
Kennys Bookstore
(Olney, MD, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Academic Press. Condizione libro: New. Editor(s): Gray, Steven. Num Pages: 748 pages, 50. BIC Classification: MFCC; MJCL. Category: (P) Professional & Vocational. Dimension: 200 x 242 x 42. Weight in Grams: 1722. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Codice libro della libreria V9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 107,30
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: U.S.A. a: Italia
Destinazione, tempi e costi

6.

Gray, Steven
Editore: Elsevier Science Publishing Co Inc (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Quantità: > 20
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Elsevier Science Publishing Co Inc, 2015. HRD. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria FD-9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 100,13
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 11,19
Da: Regno Unito a: Italia
Destinazione, tempi e costi

7.

ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Quantità: 1
Da
BWB
(Valley Stream, NY, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Condizione libro: New. Depending on your location, this item may ship from the US or UK. Codice libro della libreria 97801280020630000000

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 116,70
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: U.S.A. a: Italia
Destinazione, tempi e costi

8.

Editore: Academic Press (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Rilegato Quantità: 1
Da
Valutazione libreria
[?]

Descrizione libro Academic Press, 2015. Condizione libro: New. Codice libro della libreria EH9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 114,16
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,99
Da: Germania a: Italia
Destinazione, tempi e costi

9.

Steven Gray
Editore: Oxford Elsevier LTD Aug 2015 (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Quantità: 1
Da
Rheinberg-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Oxford Elsevier LTD Aug 2015, 2015. Buch. Condizione libro: Neu. Neuware - Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector. The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver). The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Concisely summarizes the therapeutic implications of recent, large-scale epigenome studies, including the cancer epigenome atlas Discusses targeted isoform specific versus pan-specific inhibitors, a rational drug design approach to epigenetics relevant to pharmacoepigenetic clinical applications Covers new findings in the interplay between cancer stem cells (CSCs) and drug resistance, demonstrating that epigenetic machinery is a candidate target for the eradication of these CSCs 721 pp. Englisch. Codice libro della libreria 9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 113,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,90
Da: Germania a: Italia
Destinazione, tempi e costi

10.

Steven Gray
Editore: Oxford Elsevier LTD Aug 2015 (2015)
ISBN 10: 0128002069 ISBN 13: 9780128002063
Nuovi Quantità: 1
Da
Agrios-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Oxford Elsevier LTD Aug 2015, 2015. Buch. Condizione libro: Neu. Neuware - Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector. The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver). The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Concisely summarizes the therapeutic implications of recent, large-scale epigenome studies, including the cancer epigenome atlas Discusses targeted isoform specific versus pan-specific inhibitors, a rational drug design approach to epigenetics relevant to pharmacoepigenetic clinical applications Covers new findings in the interplay between cancer stem cells (CSCs) and drug resistance, demonstrating that epigenetic machinery is a candidate target for the eradication of these CSCs 721 pp. Englisch. Codice libro della libreria 9780128002063

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 113,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,90
Da: Germania a: Italia
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro